Loading clinical trials...
Loading clinical trials...
The aim of this study was to determine whether long-term (≥ 6 months at the target dose) blockade of ETA receptors using sitaxsentan showed functional benefit in subjects with chronic Heart Failure an...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT06015776 · Diastolic Heart Failure, Heart Failure With Preserved Ejection Fraction
NCT05064709 · Heart Failure, Heart Failure With Preserved Ejection Fraction, and more
NCT05408559 · Diastolic Dysfunction, Systolic Dysfunction, and more
NCT03338374 · Diastolic Heart Failure
NCT04937790 · Heart Failure, Systolic Heart Failure, and more
University of Alabama at Birmingham
Birmingham, Alabama
Mobile Heart Specialists, PC
Mobile, Alabama
Preventative and Research Cardiloogy Providence Hospital
Mobile, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions